Our Business Model

The current for-profit business model used by pharmaceutical companies has been instrumental in the development of many innovative drugs in use today. However, for the most part, only those basic science discoveries with high potential for financial reward are developed further by for-profit companies, leaving behind many untapped opportunities ('financial orphans').

By adopting a non-profit drug development model, GlobalCures can focus on these 'financial orphans', ideas that are currently discarded. Thus GlobalCures fills an important gap and is complementary in its approach to established pharmaceutical companies, as illustrated in the table and diagram below.